Nicardipine Arrrow (Nicardipine Hydrochloride)

Nicardipine Hydrochloride, the active ingredient in Nicardipine Arrrow, is a calcium channel blocker (dihydropyridine) presented as an intravenous solution for IV use. It is employed to manage severe hypertension and angina by causing vascular smooth‑muscle relaxation, thereby lowering peripheral resistance and myocardial oxygen demand, and is administered under continuous hemodynamic monitoring in hospital environments.

GNH USA supplies Nicardipine Arrrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nicardipine is a dihydropyridine calcium‑channel blocker used in cardiovascular care.

Hypertensive emergencies: rapid reduction of dangerously high blood pressure to prevent organ damage. Severe hypertension: controlled lowering of sustained high arterial pressure. Angina pectoris: alleviation of chest pain by improving myocardial oxygen supply. Controlled hypotension during surgery: intentional blood‑pressure lowering to reduce surgical bleeding.

Nicardipine may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of the skin. - Tachycardia: increased heart rate, often compensatory. - Peripheral edema: swelling of the lower extremities. - Nausea: occasional gastrointestinal upset. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Severe hypotension: dangerous drop in blood pressure. - Myocardial ischemia: reduced blood flow to the heart. - Bradycardia: abnormally slow heart rate. - Allergic reactions: rash, itching, or anaphylaxis. - Hepatic dysfunction: elevated liver enzymes. - Thrombocytopenia: low platelet count.

When using Nicardipine, careful monitoring and specific precautions are required.

Blood pressure monitoring: observe for rapid falls in pressure. Cardiac function: avoid in patients with severe aortic stenosis. Drug interactions: review concomitant vasodilators. Renal/hepatic impairment: adjust monitoring frequency. Pregnancy and lactation: use only if clearly needed. Store at ambient temperature: keep in original container, protect from light and moisture.

Nicardipine can interact with several medicines; awareness of the level of interaction helps guide therapy.

Major Interactions (Avoid): - Concurrent use with other potent vasodilators (e.g., nitroprusside) – risk of severe hypotension. - Combination with beta‑blockers in patients with compromised cardiac output – may precipitate bradycardia.

Moderate Interactions (Monitor Closely): - Non‑dihydropyridine calcium channel blockers – additive blood‑pressure lowering. - CYP3A4 inhibitors (e.g., erythromycin, clarithromycin) – increase nicardipine plasma levels. - CYP3A4 inducers (e.g., rifampin) – reduce nicardipine exposure.